Itopride
- Generic Name
- Itopride
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H26N2O4
- CAS Number
- 122898-67-3
- Unique Ingredient Identifier
- 81BMQ80QRL
- Background
Itopride is a dopamine D2 antagonist with acetylcholinesterase inhibitory actions.
- Indication
Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).
- Associated Conditions
- Abdominal Pain, Anorexia, Dyspepsia, Functional Dyspepsia, Gastroenteritis, Nausea, Nausea and vomiting, Vomiting, Abdominal bloating, Pyrosis, Stomach discomfort
- Associated Therapies
- -
Efficacy and Safety of Itopride vs Placebo in Heartburn
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-09-29
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 48
- Registration Number
- NCT00382577
- Locations
- 🇺🇸
The Oklahoma Foundation for Digestive Research, Oklahoma City, Oklahoma, United States
Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia
- First Posted Date
- 2006-08-30
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 25
- Registration Number
- NCT00370084
- Locations
- 🇦🇺
University of Adelaide, Department of Medicine, Adelaide, South Australia, Australia
A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 45
- Registration Number
- NCT00308399
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-06-01
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 645
- Registration Number
- NCT00112190
- Locations
- 🇨🇦
AXCAN Pharma Inc., Mont St-Hilaire, Quebec, Canada
Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-06-01
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 466
- Registration Number
- NCT00112203
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath